Prolonged Dual Antiplatelet Therapy in Acute Myocardial Infarction Patients Without Revascularization: China Acute Myocardial Infarction Registry Study-Reference-Cited by-同舟云学术

Prolonged Dual Antiplatelet Therapy in Acute Myocardial Infarction Patients Without Revascularization: China Acute Myocardial Infarction Registry Study

Published:2024-04 Issue: Volume:217 Page:39-48
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Huang Cunrong,Yang Jingang,Li Ling,He Shenghu,Zhang Xuxia,Xu Haiyan,Wu Yuan,Zhang Jun,Qiao Shubin,Wu Yongjian,Zhao Yanyan,Wang Yang,Li Wei,Jin Chen,Gao Xiaojin^ORCID,Yang Yuejin

Publisher

Elsevier BV

Reference28 articles.

1. Dual antiplatelet therapy de-escalation strategies;Sinnaeve;Am J Cardiol,2021

2. Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey;Cao;Eur Heart J,2021

3. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice guidelines;Levine;J Am Coll Cardiol,2016

4. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS;Valgimigli;Eur J Cardiothorac Surg,2018

5. Defining strategies of modulation of antiplatelet therapy in patients with coronary artery disease: a consensus document from the Academic Research Consortium;Capodanno;Circulation,2023

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Longer-Duration Dual Antiplatelet Therapy in Medically-Treated Patients after Myocardial Infarction: What is the Strength of the Evidence?;The American Journal of Cardiology;2024-06